Author:
She Xiaoling,Yu Zhibin,Cui Yulong,Lei Qianqian,Wang Zeyou,Xu Gang,Luo Zhaohui,Li Guiyuan,Wu Minghua
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference38 articles.
1. Chen L, Zhang Y, Yang J, Hagan JP, Li M. Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies. Biochim Biophys Acta. 2013;1836:158–65. doi: 10.1016/j.bbcan.2013.04.003 .
2. Lwin Z, Macfadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N, Mason WP. Glioblastoma management in the temozolomide era: have we improved outcome? J Neurooncol. 2013;115:303–10. doi: 10.1007/s11060-013-1230-3 .
3. Menéndez P, Villarejo P, Padilla D, Menéndez JM, Rodríguez-Montes JA. Implications of the histological determination of microRNAs in the screening, diagnosis and prognosis of colorectal cancer. J Surg Oncol. 2013;108:70–3. doi: 10.1002/jso.23344 .
4. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol. 2013;15:546–54. doi: 10.1038/ncb2769 .
5. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 2010;1352:255–64. doi: 10.1016/j.brainres.2010.07.009 .
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献